Search results
Found 6456 matches for
An internationally recognised centre of excellence for biomedical and clinical research and teaching
Champion for the Academy of Medical Sciences (AMS) Springboard Awards
24 February 2026
MSD is inviting EOIs to become Oxford’s next Champion for the Academy of Medical Sciences (AMS) Springboard Awards .
New bone marrow model offers scalable platform for next-generation drug discovery
23 February 2026
Researchers at the MRC Weatherall Institute of Molecular Medicine have developed the first combined human bone and bone marrow organoid platform capable of modelling long-term blood and immune cell production in a fully human 3D system.
School trips key factor in belonging at school – new survey
20 February 2026
Students value school trips most highly in fostering a sense of belonging at school, according to a survey of tens of thousands of pupils in England.
Nuffield Department of Clinical Neurosciences professors amongst first Group Leaders announced for new dedicated Parkinson's Research Centre
19 February 2026
Professors Laura Parkkinen and Peter Magill have been appointed to UK DRI Group Leader roles.
COVID-19 Vaccination During Pregnancy Offers New Insight into Preeclampsia Prevention
18 February 2026
A new multinational study from the INTERCOVID Consortium, led by researchers from the University of Oxford, has found that COVID-19 vaccination during pregnancy, particularly when combined with a booster dose, significantly reduces the risk of preeclampsia, a serious and potentially life-threatening pregnancy complication. The findings offer unprecedented insight into preeclampsia prevention, independent of the direct effects of COVID-19 infection.
New Study highlights demographic shift of visceral leishmaniasis to older patients and increased incidence of relapses in Brazil
18 February 2026
A new study into visceral leishmaniasis (VL) in Brazil has created the most comprehensive picture of the disease in the country, and highlighted trends including more older patients being diagnosed with the disease and more patients presenting with relapses over time.
Existing hospital analysers offer a low-cost method to screen for fake vaccines
17 February 2026
An international team of researchers led by the University of Oxford and Oxford University Hospitals NHS Foundation Trust have demonstrated that hospital analysers can be used to identify fake liquid medical products.
'Hidden' costs of social care after a hip fracture exceed £1.25 billion a year in the UK
16 February 2026
Social care for hip fracture costs the NHS over £1.25 billion, equating to £15K per patient every year, according to a new study by the Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS).
New AI model could improve prediction of medium-term mortality in heart failure patients
16 February 2026
Researchers from the University of Oxford and international collaborators have developed a new artificial intelligence model that can more accurately predict the medium-term risk of death for people with heart failure using routine electronic health records.
Epilepsy and the brain
16 February 2026
Epilepsy is one of the most common neurological disorders, affecting roughly 50 million people around the world. Researchers at Oxford are looking at how epilepsy can be prevented, diagnosed and treated. Our experts are also raising awareness of the condition to reduce stigma and improve the quality of life for people with epilepsy, particularly those in under-resourced communities.
Drugs identified that could help prevent delirium after surgery
12 February 2026
A new study has found that several commonly used drugs could significantly reduce the risk of delirium in older people following surgery.
Sixty Seconds with Paul Leeson
12 February 2026
Professor Paul Leeson is a Cardiologist and clinical academic in the Radcliffe Department of Medicine, and recently took up the divisional role of Academic Lead for Innovation. Paul has extensive experience in translational research, industry partnerships, and spin-out leadership, including founding Ultromics and chairing the NIHR i4i Product Development Awards Committee. In this interview, Paul tells us about his career to date, his commitment to improving patient care through innovation, and his vision for strengthening the Medical Sciences Division’s innovation ecosystem.
AI ‘digital assistant’ could transform fetal ultrasound training and support
11 February 2026
Researchers from the University of Oxford, including clinicians and scientists from the Nuffield Department of Women’s & Reproductive Health (WRH), have developed a new artificial intelligence (AI) system to assist clinicians during fetal ultrasound scans in real time.
Smoking remains stubbornly higher among disadvantaged groups, new research confirms
11 February 2026
New research finds people experiencing socioeconomic disadvantage are more likely to smoke, more addicted, and less likely to attempt to quit – a pattern that holds across different types of disadvantage.
New study reveals how egg cells mature in anolis lizards
10 February 2026
Researchers from the Nuffield Department of Women's & Reproductive Health (NDWRH) and the MD Anderson Cancer Center shed light into the egg cell maturation in lizard ovaries by providing a detailed characterisation of the individual stages a reptile egg cell must pass through before it ovulates.
Oxford to advance mental health research through £1.5 million gift
10 February 2026
The University of Oxford has received a £1.5 million gift from Bukhman Philanthropies to support new research aiming to tackle one of the most pressing challenges of our time – young people’s mental health.
‘Peer power’ transforming HIV testing among fishing communities in Uganda
9 February 2026
In Uganda’s fishing communities, Dr Joseph Matovu is leading a peer-led HIV self-testing project to overcome stigma and healthcare access barriers. With support from the Africa Oxford Initiative (AfOx), the PEST4MEN model empowers local leaders to distribute self-test kits, improving uptake, linkage to care, and community ownership of HIV prevention.
The Oxford-Harrington Rare Disease Centre advances discovery of therapies for Friedreich’s Ataxia (FA)
9 February 2026
Philanthropic funding from the Friedreich's Ataxia Alliance Innovation Fund awarded to five Oxford researchers to support development of novel therapeutics.
Public trust in health data sharing for AI is conditional
9 February 2026
Public support for sharing health data for artificial intelligence (AI) research depends on clear public benefit, strong safeguards, and meaningful consent, according to a new Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS) study based on in-depth focus groups with members of the UK public.
